Acadia Pharmaceuticals | ACAD - Stock



Acadia Pharmaceuticals reported $26.12M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
ALKERMES USD 191.92M 8.49M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Biogen USD 2.27B 400K Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Corcept Therapeutics USD 12.28M 3.26M Jun/2025
Cytokinetics 0 0 Dec/2023
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
J&J USD 12.66B 215M Mar/2025
Moderna USD 240M 112M Jun/2025
Neurocrine Biosciences USD 56.9M 2.2M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
PTC Therapeutics USD 34.06M 12.39M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025